Aker BioMarine ASA – Annual Report 2025

26 March 2026: Aker BioMarine ASA today publishes its Annual Report for 2025, which includes the annual accounts, the sustainability statement and the auditor's report for 2025.

The report is attached and is also available at www.akerbiomarine.com.

Aker BioMarine ASA has also published its annual financial statements in European Single Electronic Format (ESEF), available as an attachment to this release.

For further information, please contact Christopher Robin Vinter, SVP Finance Mobile: +47 911 60 820 Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

About Aker BioMarine Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.